Ternary nanocomplexes of HA conjugates with poly(hexamethylene biguanide) and chitosan were to deliver an anti-KRAS siRNA to colorectal cancer cells, exploiting the interaction of HA with CD44 as a means to achieve selective targeting of CD44-positive cancer cells [188]. The gene discussed is CD44; the disease is cancer.